<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658827"><TermName>insulin glulisine</TermName><TermPronunciation>(IN-suh-lin GLOO-lih-seen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the laboratory. Insulin glulisine gets into the blood faster than insulin when it is injected under the skin before or shortly after a meal. It is a type of therapeutic insulin. Also called Apidra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726148" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;insulin glulisine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726149" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;insulina glulisina&quot;" language="es" id="_4"/><SpanishTermName>insulina glulisina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para controlar la cantidad de azúcar en la sangre de pacientes de diabetes mellitus. Es una forma de la hormona insulina que se produce en el laboratorio. La insulina glulisina llega más rápido a la sangre que la insulina cuando se inyecta debajo de la piel antes o muy poco después de una comida. Es un tipo de insulina terapéutica. También se llama Apidra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-03-30</DateFirstPublished></GlossaryTerm>
